Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Sell
20
HRTS Quote, Financials, Valuation and Earnings
Last price:
$28.94
Seasonality move
:
10.49%
Day range:
$29.27 - $29.51
52-week range:
$28.77 - $36.03
Dividend yield:
0.49%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
23.6K
Avg. volume:
17.9K
1-year change:
-7.43%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$29.39 | -- | -- | -- | $0.47 | 0.49% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.42 | -- | -- | -- | $0.15 | 0.82% | -- |
|
CANC
Tema Oncology ETF
|
$24.94 | -- | -- | -- | $0.96 | 2.92% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.67 | -- | -- | -- | $0.00 | 0% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$26.55 | -- | -- | -- | $0.55 | 1.89% | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
$24.67 | -- | -- | -- | $0.26 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.482 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.018 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 1.218 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.470 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 1.097 | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- | -- |
Tema GLP-1, Obesity & Cardiometabolic ETF vs. Competitors
-
Which has Higher Returns HRTS or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema GLP-1, Obesity & Cardiometabolic ETF's net margin of --. Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HRTS or AGNG?
Tema GLP-1, Obesity & Cardiometabolic ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema GLP-1, Obesity & Cardiometabolic ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema GLP-1, Obesity & Cardiometabolic ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HRTS or AGNG More Risky?
Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.780, suggesting its less volatile than the S&P 500 by 21.991%.
-
Which is a Better Dividend Stock HRTS or AGNG?
Tema GLP-1, Obesity & Cardiometabolic ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.49%. Global X Aging Population ETF offers a yield of 0.82% to investors and pays a quarterly dividend of $0.15 per share. Tema GLP-1, Obesity & Cardiometabolic ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or AGNG?
Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema GLP-1, Obesity & Cardiometabolic ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema GLP-1, Obesity & Cardiometabolic ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema GLP-1, Obesity & Cardiometabolic ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HRTS or CANC?
Tema Oncology ETF has a net margin of -- compared to Tema GLP-1, Obesity & Cardiometabolic ETF's net margin of --. Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About HRTS or CANC?
Tema GLP-1, Obesity & Cardiometabolic ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema GLP-1, Obesity & Cardiometabolic ETF has higher upside potential than Tema Oncology ETF, analysts believe Tema GLP-1, Obesity & Cardiometabolic ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is HRTS or CANC More Risky?
Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or CANC?
Tema GLP-1, Obesity & Cardiometabolic ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.49%. Tema Oncology ETF offers a yield of 2.92% to investors and pays a quarterly dividend of $0.96 per share. Tema GLP-1, Obesity & Cardiometabolic ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or CANC?
Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. Tema GLP-1, Obesity & Cardiometabolic ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, Tema GLP-1, Obesity & Cardiometabolic ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema GLP-1, Obesity & Cardiometabolic ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns HRTS or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Tema GLP-1, Obesity & Cardiometabolic ETF's net margin of --. Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About HRTS or HTEC?
Tema GLP-1, Obesity & Cardiometabolic ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema GLP-1, Obesity & Cardiometabolic ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Tema GLP-1, Obesity & Cardiometabolic ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is HRTS or HTEC More Risky?
Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.075, suggesting its more volatile than the S&P 500 by 7.497%.
-
Which is a Better Dividend Stock HRTS or HTEC?
Tema GLP-1, Obesity & Cardiometabolic ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.49%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tema GLP-1, Obesity & Cardiometabolic ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or HTEC?
Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Tema GLP-1, Obesity & Cardiometabolic ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Tema GLP-1, Obesity & Cardiometabolic ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema GLP-1, Obesity & Cardiometabolic ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns HRTS or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema GLP-1, Obesity & Cardiometabolic ETF's net margin of --. Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About HRTS or MEDX?
Tema GLP-1, Obesity & Cardiometabolic ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema GLP-1, Obesity & Cardiometabolic ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema GLP-1, Obesity & Cardiometabolic ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is HRTS or MEDX More Risky?
Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or MEDX?
Tema GLP-1, Obesity & Cardiometabolic ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.49%. Horizon Kinetics Medical ETF offers a yield of 1.89% to investors and pays a quarterly dividend of $0.55 per share. Tema GLP-1, Obesity & Cardiometabolic ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or MEDX?
Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema GLP-1, Obesity & Cardiometabolic ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema GLP-1, Obesity & Cardiometabolic ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema GLP-1, Obesity & Cardiometabolic ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
-
Which has Higher Returns HRTS or MNTL?
Tema Neuroscience and Mental Health ETF has a net margin of -- compared to Tema GLP-1, Obesity & Cardiometabolic ETF's net margin of --. Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of -- beat Tema Neuroscience and Mental Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- MNTLTema Neuroscience and Mental Health ETF-- -- -- -
What do Analysts Say About HRTS or MNTL?
Tema GLP-1, Obesity & Cardiometabolic ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Neuroscience and Mental Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema GLP-1, Obesity & Cardiometabolic ETF has higher upside potential than Tema Neuroscience and Mental Health ETF, analysts believe Tema GLP-1, Obesity & Cardiometabolic ETF is more attractive than Tema Neuroscience and Mental Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 MNTLTema Neuroscience and Mental Health ETF0 0 0 -
Is HRTS or MNTL More Risky?
Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Neuroscience and Mental Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or MNTL?
Tema GLP-1, Obesity & Cardiometabolic ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.49%. Tema Neuroscience and Mental Health ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.26 per share. Tema GLP-1, Obesity & Cardiometabolic ETF pays -- of its earnings as a dividend. Tema Neuroscience and Mental Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or MNTL?
Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues are --, which are smaller than Tema Neuroscience and Mental Health ETF quarterly revenues of --. Tema GLP-1, Obesity & Cardiometabolic ETF's net income of -- is lower than Tema Neuroscience and Mental Health ETF's net income of --. Notably, Tema GLP-1, Obesity & Cardiometabolic ETF's price-to-earnings ratio is -- while Tema Neuroscience and Mental Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema GLP-1, Obesity & Cardiometabolic ETF is -- versus -- for Tema Neuroscience and Mental Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -- MNTLTema Neuroscience and Mental Health ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 10
IonQ [IONQ] is up 7.07% over the past day.
Sell
47
CEG alert for Jan 10
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
8
CRNX alert for Jan 10
Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.
